{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:18:10Z","timestamp":1788351490953,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI145435-A1"],"award-info":[{"award-number":["R01-AI145435-A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI153349"],"award-info":[{"award-number":["R01-AI153349"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL131829"],"award-info":[{"award-number":["R01-HL131829"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["S10-OD030381-A1"],"award-info":[{"award-number":["S10-OD030381-A1"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61700-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T19:17:05Z","timestamp":1752175025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["18F-Fluorodeoxysorbitol PET for noninvasive detection of invasive mold infections: preclinical and first-in-human studies"],"prefix":"10.1038","volume":"16","author":[{"given":"Carlos E.","family":"Ruiz-Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar J.","family":"Nino-Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8333-7180","authenticated-orcid":false,"given":"Yuderleys","family":"Masias-Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4318-0628","authenticated-orcid":false,"given":"Amy","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelynn","family":"Shambles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1574-7759","authenticated-orcid":false,"given":"Xueyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0971-3635","authenticated-orcid":false,"given":"Elizabeth W.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Lodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence S.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia S.","family":"Kates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-7070","authenticated-orcid":false,"given":"Sanjay K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"61700_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJMra1216008","volume":"371","author":"M McCarthy","year":"2014","unstructured":"McCarthy, M., Rosengart, A., Schuetz, A. N., Kontoyiannis, D. P. & Walsh, T. J. Mold infections of the central nervous system. N. Engl. J. Med 371, 150\u2013160 (2014).","journal-title":"N. Engl. J. Med"},{"key":"61700_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3947\/ic.2022.0151","volume":"55","author":"SO Lee","year":"2023","unstructured":"Lee, S. O. Diagnosis and treatment of invasive mold diseases. Infect. Chemother. 55, 10\u201321 (2023).","journal-title":"Infect. Chemother."},{"key":"61700_CR3","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning, D.W. Global incidence and mortality of severe fungal disease. Lancet Infect. Dis. 24, e428\u2013e438 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"61700_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","volume":"7","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl, M. et al. COVID-19-associated fungal infections. Nat. Microbiol 7, 1127\u20131140 (2022).","journal-title":"Nat. Microbiol"},{"key":"61700_CR5","doi-asserted-by":"publisher","first-page":"101393","DOI":"10.1016\/j.mycmed.2023.101393","volume":"33","author":"G Pasquier","year":"2023","unstructured":"Pasquier, G. COVID-19-associated mucormycosis in India: why such an outbreak?. J. Mycol. Med 33, 101393 (2023).","journal-title":"J. Mycol. Med"},{"key":"61700_CR6","doi-asserted-by":"publisher","first-page":"e01244","DOI":"10.1128\/AAC.01244-19","volume":"63","author":"F Lamoth","year":"2019","unstructured":"Lamoth, F. & Kontoyiannis, D. P. Therapeutic challenges of non-aspergillus invasive mold infections in immunosuppressed patients. Antimicrob. Agents Chemother. 63, e01244\u2013e01319 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61700_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jpids\/piu074","volume":"4","author":"RL Wattier","year":"2015","unstructured":"Wattier, R. L. et al. A prospective, International Cohort Study of invasive mold infections in children. J. Pediatr. Infect. Dis. Soc. 4, 313\u2013322 (2015).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"61700_CR8","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","volume":"21","author":"M Hoenigl","year":"2021","unstructured":"Hoenigl, M. et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect. Dis. 21, e246\u2013e257 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"61700_CR9","unstructured":"World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. https:\/\/www.who.int\/publications\/i\/item\/9789240060241 (2022)."},{"key":"61700_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/cid\/ciad599","volume":"78","author":"SP Bergin","year":"2024","unstructured":"Bergin, S. P. et al. Plasma microbial cell-free DNA sequencing in immunocompromised patients with pneumonia: a prospective observational study. Clin. Infect. Dis. 78, 775\u2013784 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"61700_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","volume":"4","author":"TA Blauwkamp","year":"2019","unstructured":"Blauwkamp, T. A. et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat. Microbiol 4, 663\u2013674 (2019).","journal-title":"Nat. Microbiol"},{"key":"61700_CR12","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1093\/cid\/ciaa1786","volume":"72","author":"T Mercier","year":"2021","unstructured":"Mercier, T. et al. Defining galactomannan positivity in the updated EORTC\/MSGERC consensus definitions of invasive fungal diseases. Clin. Infect. Dis. 72, S89\u2013S94 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"61700_CR13","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1128\/JCM.00345-17","volume":"55","author":"W Zhou","year":"2017","unstructured":"Zhou, W. et al. Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis. J. Clin. Microbiol 55, 2153\u20132161 (2017).","journal-title":"J. Clin. Microbiol"},{"key":"61700_CR14","doi-asserted-by":"publisher","first-page":"eaax8251","DOI":"10.1126\/scitranslmed.aax8251","volume":"11","author":"AA Ordonez","year":"2019","unstructured":"Ordonez, A.A., et al. Molecular imaging of bacterial infections: Overcoming the barriers to clinical translation. Sci. Transl. Med. 11, eaax8251 (2019).","journal-title":"Sci. Transl. Med."},{"key":"61700_CR15","doi-asserted-by":"publisher","first-page":"S249","DOI":"10.1093\/infdis\/jiad078","volume":"228","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Visualizing bacterial infections with novel targeted molecular imaging approaches. J. Infect. Dis. 228, S249\u2013S258 (2023).","journal-title":"J. Infect. Dis."},{"key":"61700_CR16","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.1093\/infdis\/jiad067","volume":"228","author":"J Lai","year":"2023","unstructured":"Lai, J., Wang, B., Petrik, M., Beziere, N. & Hammoud, D. A. Radiotracer development for fungal-specific imaging: past, present, and future. J. Infect. Dis. 228, S259\u2013S269 (2023).","journal-title":"J. Infect. Dis."},{"key":"61700_CR17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2214\/ajr.150.5.1015","volume":"150","author":"JE Kuhlman","year":"1988","unstructured":"Kuhlman, J. E. et al. CT of invasive pulmonary aspergillosis. AJR Am. J. Roentgenol. 150, 1015\u20131020 (1988).","journal-title":"AJR Am. J. Roentgenol."},{"key":"61700_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/qjmed\/hcy128","volume":"111","author":"B Leroy-Freschini","year":"2018","unstructured":"Leroy-Freschini, B. et al. 18F-FDG PET\/CT for invasive fungal infection in immunocompromised patients. QJM 111, 613\u2013622 (2018).","journal-title":"QJM"},{"key":"61700_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/diagnostics11010137","volume":"11","author":"AO Ankrah","year":"2021","unstructured":"Ankrah, A.O., et al. The Added Value of [(18)F]FDG PET\/CT in the Management of Invasive Fungal Infections. Diagnostics 11, 137 (2021).","journal-title":"Diagnostics"},{"key":"61700_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2214\/AJR.13.11712","volume":"203","author":"P Sharma","year":"2014","unstructured":"Sharma, P., Mukherjee, A., Karunanithi, S., Bal, C. & Kumar, R. Potential role of 18F-FDG PET\/CT in patients with fungal infections. AJR Am. J. Roentgenol. 203, 180\u2013189 (2014).","journal-title":"AJR Am. J. Roentgenol."},{"key":"61700_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2967\/jnumed.109.072462","volume":"51","author":"M Petrik","year":"2010","unstructured":"Petrik, M. et al. 68Ga-siderophores for PET imaging of invasive pulmonary aspergillosis: proof of principle. J. Nucl. Med. 51, 639\u2013645 (2010).","journal-title":"J. Nucl. Med."},{"key":"61700_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11307-013-0654-7","volume":"16","author":"M Petrik","year":"2014","unstructured":"Petrik, M. et al. 68Ga-triacetylfusarinine C and 68Ga-ferrioxamine E for Aspergillus infection imaging: uptake specificity in various microorganisms. Mol. Imaging Biol. 16, 102\u2013108 (2014).","journal-title":"Mol. Imaging Biol."},{"key":"61700_CR23","doi-asserted-by":"publisher","first-page":"E1026","DOI":"10.1073\/pnas.1518836113","volume":"113","author":"AM Rolle","year":"2016","unstructured":"Rolle, A. M. et al. ImmunoPET\/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo. Proc. Natl Acad. Sci. USA 113, E1026\u20131033 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"61700_CR24","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.7150\/thno.20919","volume":"7","author":"G Davies","year":"2017","unstructured":"Davies, G. et al. Towards translational immunoPET\/MR imaging of invasive pulmonary aspergillosis: the humanised monoclonal antibody JF5 detects aspergillus lung infections in vivo. Theranostics 7, 3398\u20133414 (2017).","journal-title":"Theranostics"},{"key":"61700_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fmicb.2018.00691","volume":"9","author":"CR Thornton","year":"2018","unstructured":"Thornton, C. R. Molecular imaging of invasive pulmonary aspergillosis using immunoPET\/MRI: the future looks bright. Front. Microbiol. 9, 691 (2018).","journal-title":"Front. Microbiol."},{"key":"61700_CR26","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/s41467-021-21965-z","volume":"12","author":"S Henneberg","year":"2021","unstructured":"Henneberg, S., et al. Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatment. Nat. Commun. 12, 1707 (2021).","journal-title":"Nat. Commun."},{"key":"61700_CR27","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1038\/s41467-022-29553-5","volume":"13","author":"DY Kim","year":"2022","unstructured":"Kim, D. Y., et al. In vivo imaging of invasive aspergillosis with (18)F-fluorodeoxysorbitol positron emission tomography. Nat. Commun. 13, 1926 (2022).","journal-title":"Nat. Commun."},{"key":"61700_CR28","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s00259-024-06760-4","volume":"51","author":"J Lai","year":"2024","unstructured":"Lai, J. et al. PET imaging of Aspergillus infection using Zirconium-89 labeled anti-beta-glucan antibody fragments. Eur. J. Nucl. Med Mol. Imaging 51, 3223\u20133234 (2024).","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"61700_CR29","doi-asserted-by":"publisher","first-page":"eadl5934","DOI":"10.1126\/scitranslmed.adl5934","volume":"16","author":"S Shah","year":"2024","unstructured":"Shah, S. et al. Development and preclinical validation of 2-deoxy 2-[(18)F]fluorocellobiose as an Aspergillus-specific PET tracer. Sci. Transl. Med. 16, eadl5934 (2024).","journal-title":"Sci. Transl. Med."},{"key":"61700_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/jlcr.4116","volume":"67","author":"F Basuli","year":"2024","unstructured":"Basuli, F. et al. Fully automated cassette-based synthesis of 2-Deoxy-2-[(18)F]fluorocellobiose using trasis allinone module. J. Label. Comp. Radiopharm. 67, 308\u2013313 (2024).","journal-title":"J. Label. Comp. Radiopharm."},{"key":"61700_CR31","doi-asserted-by":"publisher","unstructured":"Schwenck, J., et al. Antibody-guided molecular imaging of aspergillus lung infections in leukemia patients. J. Nucl. Med. https:\/\/doi.org\/10.2967\/jnumed.121.263251 (2022).","DOI":"10.2967\/jnumed.121.263251"},{"key":"61700_CR32","doi-asserted-by":"publisher","first-page":"259ra146","DOI":"10.1126\/scitranslmed.3009815","volume":"6","author":"EA Weinstein","year":"2014","unstructured":"Weinstein, E. A. et al. Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci. Transl. Med 6, 259ra146 (2014).","journal-title":"Sci. Transl. Med"},{"key":"61700_CR33","doi-asserted-by":"publisher","first-page":"eabe9805","DOI":"10.1126\/scitranslmed.abe9805","volume":"13","author":"AA Ordonez","year":"2021","unstructured":"Ordonez, A.A., et al. Imaging Enterobacterales infections in patients using pathogen-specific positron emission tomography. Sci. Transl. Med. 13, eabe9805 (2021).","journal-title":"Sci. Transl. Med."},{"key":"61700_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0141-0229(01)00346-5","volume":"29","author":"AM Elshafei","year":"2001","unstructured":"Elshafei, A. M. & Abdel-Fatah, O. M. Evidence for a non-phosphorylated route of galactose breakdown in cell-free extracts of Aspergillus niger. Enzym. Micro. Technol. 29, 76\u201383 (2001).","journal-title":"Enzym. Micro. Technol."},{"key":"61700_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.febslet.2012.01.004","volume":"586","author":"OM Koivistoinen","year":"2012","unstructured":"Koivistoinen, O. M., Richard, P., Penttila, M., Ruohonen, L. & Mojzita, D. Sorbitol dehydrogenase of Aspergillus niger, SdhA, is part of the oxido-reductive D-galactose pathway and essential for D-sorbitol catabolism. FEBS Lett. 586, 378\u2013383 (2012).","journal-title":"FEBS Lett."},{"key":"61700_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11307-007-0125-0","volume":"10","author":"ZB Li","year":"2008","unstructured":"Li, Z. B. et al. The synthesis of 18F-FDS and its potential application in molecular imaging. Mol. Imaging Biol. 10, 92\u201398 (2008).","journal-title":"Mol. Imaging Biol."},{"key":"61700_CR37","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1038\/s41596-021-00613-2","volume":"16","author":"F Mota","year":"2021","unstructured":"Mota, F., De Jesus, P. & Jain, S. K. Kit-based synthesis of 2-deoxy-2-[(18)F]-fluoro-D-sorbitol for bacterial imaging. Nat. Protoc. 16, 5274\u20135286 (2021).","journal-title":"Nat. Protoc."},{"key":"61700_CR38","unstructured":"Partners\u2019 Infectious Disease Images. Infectious Diseases Images eMicrobes Digital Library. https:\/\/www.idimages.org\/atlas (2024)."},{"key":"61700_CR39","first-page":"1597","volume":"20","author":"DR DeLone","year":"1999","unstructured":"DeLone, D. R. et al. Disseminated aspergillosis involving the brain: distribution and imaging characteristics. AJNR Am. J. Neuroradiol. 20, 1597\u20131604 (1999).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"61700_CR40","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1148\/rg.264055152","volume":"26","author":"AD Tempkin","year":"2006","unstructured":"Tempkin, A. D., Sobonya, R. E., Seeger, J. F. & Oh, E. S. Cerebral aspergillosis: radiologic and pathologic findings. Radiographics 26, 1239\u20131242 (2006).","journal-title":"Radiographics"},{"key":"61700_CR41","unstructured":"Mac Faddin, J.F. Biochemical tests for identification of medical bacteria, (Williams & Wilkins, Baltimore, 1976)."},{"key":"61700_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2967\/jnumed.116.181792","volume":"58","author":"AA Ordonez","year":"2017","unstructured":"Ordonez, A. A. et al. A systematic approach for developing bacteria-specific imaging tracers. J. Nucl. Med. 58, 144\u2013150 (2017).","journal-title":"J. Nucl. Med."},{"key":"61700_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/jof8010025","volume":"8","author":"J Lai","year":"2021","unstructured":"Lai, J. et al. Evaluation of 2-[(18)F]-fluorodeoxysorbitol PET imaging in preclinical models of aspergillus infection. J. Fungi 8, 25 (2021).","journal-title":"J. Fungi"},{"key":"61700_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0008-6215(98)00266-3","volume":"313","author":"ME Scott","year":"1998","unstructured":"Scott, M. E. & Viola, R. E. The use of fluoro- and deoxy-substrate analogs to examine binding specificity and catalysis in the enzymes of the sorbitol pathway. Carbohydr. Res. 313, 247\u2013253 (1998).","journal-title":"Carbohydr. Res."},{"key":"61700_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12902-020-00567-8","volume":"20","author":"Z Kong","year":"2020","unstructured":"Kong, Z., Wang, Y. & Ma, W. & Cheng, X. Role of (18)F-fluorodeoxyglucose (FDG) and (18)F-2-fluorodeoxy sorbitol (FDS) in autoimmune hypophysitis: a case report. BMC Endocr. Disord. 20, 84 (2020).","journal-title":"BMC Endocr. Disord."},{"key":"61700_CR46","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/RLU.0000000000001391","volume":"41","author":"X Cheng","year":"2016","unstructured":"Cheng, X., Zhu, W. & Cui, R. Increased 18F-2-fluorodeoxysorbitol (18F-FDS) activity in a pituitary spindle cell carcinoma. Clin. Nucl. Med 41, 953\u2013955 (2016).","journal-title":"Clin. Nucl. Med"},{"key":"61700_CR47","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/pharmaceutics13111752","volume":"13","author":"G Hugon","year":"2021","unstructured":"Hugon, G., et al. [(18)F]2-fluoro-2-deoxy-sorbitol PET imaging for quantitative monitoring of enhanced blood-brain barrier permeability induced by focused ultrasound. Pharmaceutics 13, 1752 (2021).","journal-title":"Pharmaceutics"},{"key":"61700_CR48","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/RLU.0000000000001644","volume":"42","author":"MS Javadi","year":"2017","unstructured":"Javadi, M. S., Ordonez, A. A. & Jain, S. K. Re: Increased 18F-2-fluorodeoxysorbitol (18F-FDS) activity in a pituitary spindle cell carcinoma. Clin. Nucl. Med 42, 649 (2017).","journal-title":"Clin. Nucl. Med"},{"key":"61700_CR49","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s11307-016-0946-9","volume":"18","author":"W Zhu","year":"2016","unstructured":"Zhu, W., et al. Biodistribution and Radiation Dosimetry of the Enterobacteriaceae-Specific Imaging Probe [F]Fluorodeoxysorbitol Determined by PET\/CT in Healthy Human Volunteers. Mol. Imaging Biol. 18, 782\u2013787 (2016).","journal-title":"Mol. Imaging Biol."},{"key":"61700_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/mmy\/myv091","volume":"54","author":"A Chakrabarti","year":"2016","unstructured":"Chakrabarti, A. et al. Brain abscess due to Cladophialophora bantiana: a review of 124 cases. Med Mycol. 54, 111\u2013119 (2016).","journal-title":"Med Mycol."},{"key":"61700_CR51","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/S1470-2045(20)30751-8","volume":"22","author":"H Hricak","year":"2021","unstructured":"Hricak, H. et al. Medical imaging and nuclear medicine: a Lancet Oncology Commission. Lancet Oncol. 22, e136\u2013e172 (2021).","journal-title":"Lancet Oncol."},{"key":"61700_CR52","doi-asserted-by":"publisher","first-page":"ofaa132","DOI":"10.1093\/ofid\/ofaa132","volume":"7","author":"WF Wright","year":"2020","unstructured":"Wright, W. F. & Auwaerter, P. G. Fever and fever of unknown origin: review, recent advances, and lingering dogma. Open Forum Infect. Dis. 7, ofaa132 (2020).","journal-title":"Open Forum Infect. Dis."},{"key":"61700_CR53","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.crad.2017.04.014","volume":"72","author":"T Bharucha","year":"2017","unstructured":"Bharucha, T. et al. Diagnostic yield of FDG-PET\/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise. Clin. Radio. 72, 764\u2013771 (2017).","journal-title":"Clin. Radio."},{"key":"61700_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cpet.2020.09.011","volume":"16","author":"TJ Henrich","year":"2021","unstructured":"Henrich, T. J., Jones, T., Beckford-Vera, D., Price, P. M. & VanBrocklin, H. F. Total-body PET imaging in infectious diseases. PET Clin. 16, 89\u201397 (2021).","journal-title":"PET Clin."},{"key":"61700_CR55","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1365-2141.2005.05379.x","volume":"128","author":"LA McLintock","year":"2005","unstructured":"McLintock, L. A., Gibson, B. E. & Jones, B. L. Mixed pulmonary fungal infection with Aspergillus fumigatus and Absidia corymbifera in a patient with relapsed acute myeloid leukaemia. Br. J. Haematol. 128, 737 (2005).","journal-title":"Br. J. Haematol."},{"key":"61700_CR56","unstructured":"FDA. Guidance for industry and researchers: the radioactive drug research committee: human research without an investigational new drug application. (2010)."},{"key":"61700_CR57","unstructured":"University, J.H. Biodistribution and pathophysiology study of 18F-fluorodeoxysorbitol (18F-FDS) in diseased patients. (ClinicalTrials.gov, 2024)."},{"key":"61700_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nucmedbio.2012.10.001","volume":"40","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA. Nucl. Med Biol. 40, 89\u201396 (2013).","journal-title":"Nucl. Med Biol."},{"key":"61700_CR59","doi-asserted-by":"publisher","unstructured":"Villabona-Rueda, A., Wang, D. & D\u2019Alessio, F.R. Experimental model to evaluate resolution of pneumonia. J. Vis. Exp. https:\/\/doi.org\/10.3791\/63925 (2023).","DOI":"10.3791\/63925"},{"key":"61700_CR60","doi-asserted-by":"publisher","first-page":"e0123021","DOI":"10.1128\/JCM.01230-21","volume":"59","author":"H Badali","year":"2021","unstructured":"Badali, H. et al. Epidemiology and antifungal susceptibilities of mucoralean fungi in clinical samples from the United States. J. Clin. Microbiol 59, e0123021 (2021).","journal-title":"J. Clin. Microbiol"},{"key":"61700_CR61","doi-asserted-by":"publisher","first-page":"myad020","DOI":"10.1093\/mmy\/myad020","volume":"61","author":"M Erami","year":"2023","unstructured":"Erami, M., et al. Microbial and clinical epidemiology of invasive fungal rhinosinusitis in hospitalized COVID-19 patients, the divergent causative agents. Med. Mycol. 61, myad020 (2023).","journal-title":"Med. Mycol."},{"key":"61700_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1189\/jlb.1012518","volume":"95","author":"E Liverani","year":"2014","unstructured":"Liverani, E. et al. LPS-induced systemic inflammation is more severe in P2Y12 null mice. J. Leukoc. Biol. 95, 313\u2013323 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"61700_CR63","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/cells12101418","volume":"12","author":"E Xingi","year":"2023","unstructured":"Xingi, E., et al. LPS-induced systemic inflammation affects the dynamic interactions of astrocytes and microglia with the vasculature of the mouse brain cortex. Cells 12, 1418 (2023).","journal-title":"Cells"},{"key":"61700_CR64","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.1038\/s41467-024-50989-4","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen, X., et al. Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nat. Commun. 15, 6657 (2024).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61700-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:49:04Z","timestamp":1757224144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61700-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61700"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61700-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.K.J. is a co-inventor on pending patent USPA #63\/071,755 on the solid-phase cartridge to formulate ready-to-use\n                      18\n                      F-FDS and pending patent USPA #63\/699,572 on Noninvasive Detection of Invasive Mold Infections by\n                      18\n                      F-FDS PET, filed by Johns Hopkins University. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6395"}}